Hope for HIV/AIDS patients as FDA approves injectable drug – Though it is very expensive
By Gladys chepkemoi - 2023-01-04 05:02:19 - [General]
Tuesday, January 3, 2023 – The United States Food and Drug Administration (FDA) has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens.
Experts say the new injectable, which works with less frequent dosing, can be a game changer for those whose infections don’t respond to other treatments.
Developed by Gilead Sciences, the drug is the first of a new class called capsid inhibitors, which work by blocking the protein shell, or capsid, of the virus, disrupting multiple stages of the viral life cycle.
In a clinical trial, 83% of patients taking Sunlenca with a combination of other drugs achieved an undetectable viral load after about a year.
share on
Kindly Login or Register to comment and like and earn
Comments (0)
Others are reading
You should be compassionate and forgiving When I am afraid I put my trust in God Five things successful people do before 8am Success is something you attract by the person you become Christian Ronaldo threatens to break word history ever been made in sport word The most common Beaches in Yimbo West Ward in Bondo sub county The only dispensary in Bunyala south ward in Busia County Do the right thing when it’s hard If you don’t love someone neither use nor take things from them And a number of nations will be joined to the Lord in that day, and will become my people; and I will be living among you, and you will see that the Lord of armies has sent me to you.